Header Logo

Connection

GEORGE CHOLANKERIL to Humans

Back to Details
This is a "connection" page, showing publications GEORGE CHOLANKERIL has written about Humans.
GEORGE CHOLANKERIL
Connection Strength
0.942
Humans
  1. Unseen foe: The financial toxicity of liver transplantation. Liver Transpl. 2024 Sep 01; 30(9):873-874.
    View in: PubMed
    Score: 0.018
  2. The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults. J Pediatr Gastroenterol Nutr. 2024 Jul; 79(1):110-118.
    View in: PubMed
    Score: 0.018
  3. Reply to: "Longitudinal changes in fatty liver index are associated with risk of hepatocellular carcinoma: A nationwide cohort study in Korea". J Hepatol. 2024 May; 80(5):e218-e219.
    View in: PubMed
    Score: 0.018
  4. The clinical imperative of a complete biochemical response to immunosuppression in autoimmune hepatitis: Close is not good enough! Hepatology. 2024 03 01; 79(3):529-531.
    View in: PubMed
    Score: 0.018
  5. Survival following liver transplantation for hepatocellular carcinoma after implementation of MMaT-3 policy. Liver Transpl. 2023 10 01; 29(10):1138-1142.
    View in: PubMed
    Score: 0.017
  6. Posttransplant outcomes for alcohol-associated liver disease during the COVID-19 pandemic. Liver Transpl. 2023 07 01; 29(7):777-780.
    View in: PubMed
    Score: 0.017
  7. Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras. Clin Infect Dis. 2023 02 18; 76(4):592-599.
    View in: PubMed
    Score: 0.017
  8. Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era. Clin Gastroenterol Hepatol. 2023 08; 21(9):2288-2297.e4.
    View in: PubMed
    Score: 0.017
  9. Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease. J Hepatol. 2023 03; 78(3):493-500.
    View in: PubMed
    Score: 0.017
  10. Current Challenges and Future Direction in Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Semin Liver Dis. 2023 02; 43(1):89-99.
    View in: PubMed
    Score: 0.016
  11. Comparable Survival for Hepatitis C-Related Hepatocellular Carcinoma After Liver Transplantation Irrespective of Viremic Status. Clin Gastroenterol Hepatol. 2023 05; 21(5):1362-1364.e1.
    View in: PubMed
    Score: 0.016
  12. Clinical Factors Associated With Lack of Serological Response to SARS-CoV-2 Messenger RNA Vaccine in Liver Transplantation Recipients. Liver Transpl. 2022 01; 28(1):123-126.
    View in: PubMed
    Score: 0.016
  13. The impact of alteration in gut microbiome in the pathogenesis of nonalcoholic fatty liver disease. Curr Opin Infect Dis. 2021 10 01; 34(5):477-482.
    View in: PubMed
    Score: 0.015
  14. Gastrointestinal manifestations of coronavirus disease 2019. Curr Opin Infect Dis. 2021 10 01; 34(5):471-476.
    View in: PubMed
    Score: 0.015
  15. Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA. Hepatology. 2021 12; 74(6):3316-3329.
    View in: PubMed
    Score: 0.015
  16. Practical Consideration for Drug Monitoring of Tacrolimus in Liver Transplantation Recipients with SARS-CoV-2 Infection. Liver Transpl. 2022 01; 28(1):127-130.
    View in: PubMed
    Score: 0.015
  17. NAFLD and HCC: Time to Bridge the Gap. Hepatology. 2021 11; 74(5):2336-2338.
    View in: PubMed
    Score: 0.015
  18. Current Trends in Liver Transplantation for Alcoholic Hepatitis. Clin Liver Dis. 2021 08; 25(3):625-634.
    View in: PubMed
    Score: 0.015
  19. Early Impact of COVID-19 on Solid Organ Transplantation in the United States. Transplantation. 2020 11; 104(11):2221-2224.
    View in: PubMed
    Score: 0.014
  20. Are Proton Pump Inhibitors Contributing to SARS-COV-2 Infection? Am J Gastroenterol. 2020 11; 115(11):1920-1921.
    View in: PubMed
    Score: 0.014
  21. Association of Digestive Symptoms and Hospitalization in Patients With SARS-CoV-2 Infection. Am J Gastroenterol. 2020 07; 115(7):1129-1132.
    View in: PubMed
    Score: 0.014
  22. High Prevalence of Concurrent Gastrointestinal Manifestations in Patients With Severe Acute Respiratory Syndrome Coronavirus 2: Early Experience From California. Gastroenterology. 2020 08; 159(2):775-777.
    View in: PubMed
    Score: 0.014
  23. Recent advances in liver transplantation with HCV seropositive donors. F1000Res. 2019; 8.
    View in: PubMed
    Score: 0.014
  24. Regional Trends in Mortality from Alcohol-Induced Causes in the United States, 2000-2017. J Gen Intern Med. 2020 08; 35(8):2495-2498.
    View in: PubMed
    Score: 0.014
  25. Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation. Sci Rep. 2019 06 05; 9(1):8312.
    View in: PubMed
    Score: 0.013
  26. Inpatient Outcomes for Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention. J Clin Gastroenterol. 2019 02; 53(2):120-126.
    View in: PubMed
    Score: 0.013
  27. Temporal Trends Associated With the Rise in Alcoholic Liver Disease-related Liver Transplantation in the United States. Transplantation. 2019 01; 103(1):131-139.
    View in: PubMed
    Score: 0.013
  28. Increasing Trends in Transplantation of HCV-Positive Livers Into Uninfected Recipients. Clin Gastroenterol Hepatol. 2019 07; 17(8):1634-1636.
    View in: PubMed
    Score: 0.012
  29. Impact of Drug Overdose Deaths on Solid Organ Transplantation in the United States. J Gen Intern Med. 2018 09; 33(9):1423-1425.
    View in: PubMed
    Score: 0.012
  30. Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients. Hepatology. 2018 08; 68(2):792-793.
    View in: PubMed
    Score: 0.012
  31. Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2018 06; 16(6):965-973.e2.
    View in: PubMed
    Score: 0.012
  32. Direct-Acting Antiviral Therapy and Improvement in Graft Survival of Hepatitis C Liver Transplant Recipients. Transplantation. 2017 12; 101(12):e349.
    View in: PubMed
    Score: 0.012
  33. Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as?the Leading Indication for Liver Transplantation in the United?States. Clin Gastroenterol Hepatol. 2018 08; 16(8):1356-1358.
    View in: PubMed
    Score: 0.012
  34. Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct-Acting Antiviral Agents. Clin Gastroenterol Hepatol. 2018 03; 16(3):452-453.
    View in: PubMed
    Score: 0.012
  35. Rates of liver retransplantation in the United States are declining in the era of direct-acting antiviral agents. J Viral Hepat. 2017 12; 24(12):1194-1195.
    View in: PubMed
    Score: 0.012
  36. Optimal timing for hepatitis C antiviral therapy in the peritransplant period? Hepatology. 2017 09; 66(3):1004.
    View in: PubMed
    Score: 0.011
  37. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes. Dig Dis Sci. 2017 10; 62(10):2915-2922.
    View in: PubMed
    Score: 0.011
  38. Portomesenteric venous thrombosis complicated by a haemorrhagic shock: a rare complication of laparoscopic gastrectomy. BMJ Case Rep. 2017 May 29; 2017.
    View in: PubMed
    Score: 0.011
  39. Disparities in Liver Transplantation Resulting From Variations in Regional Donor Supply and Multiple Listing Practices. Clin Gastroenterol Hepatol. 2017 02; 15(2):313-315.
    View in: PubMed
    Score: 0.011
  40. Nonalcoholic Fatty Liver Disease: Epidemiology, Natural History, and Diagnostic Challenges. Hepatology. 2016 09; 64(3):954.
    View in: PubMed
    Score: 0.011
  41. Trends in Liver Transplantation Multiple Listing Practices Associated With Disparities in Donor Availability: An Endless Pursuit to Implement the Final Rule. Gastroenterology. 2016 09; 151(3):382-386.e2.
    View in: PubMed
    Score: 0.011
  42. Skilled nursing facility placement in hospitalized elderly patients with colon cancer. Eur J Surg Oncol. 2016 Nov; 42(11):1660-1666.
    View in: PubMed
    Score: 0.011
  43. Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C. Dig Dis Sci. 2016 09; 61(9):2505-15.
    View in: PubMed
    Score: 0.011
  44. GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA Intern Med. 2024 Nov 01; 184(11):1314-1323.
    View in: PubMed
    Score: 0.005
  45. Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018-2023. Clin Mol Hepatol. 2024 Oct; 30(4):756-770.
    View in: PubMed
    Score: 0.005
  46. Estimated pulse wave velocity in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality. J Gastroenterol Hepatol. 2024 Sep; 39(9):1950-1956.
    View in: PubMed
    Score: 0.005
  47. Steatotic liver disease-associated all-cause/cause-specific mortality in the United States. Aliment Pharmacol Ther. 2024 07; 60(1):33-42.
    View in: PubMed
    Score: 0.005
  48. Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis. Clin Mol Hepatol. 2024 Jul; 30(3):436-448.
    View in: PubMed
    Score: 0.005
  49. Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States. Expert Rev Gastroenterol Hepatol. 2024 Jan-Feb; 18(1-3):113-119.
    View in: PubMed
    Score: 0.005
  50. Association between food insecurity and metabolic dysfunction-associated steatotic liver disease/significant fibrosis measured by fibroscan. Eur J Nutr. 2024 Apr; 63(3):995-1001.
    View in: PubMed
    Score: 0.005
  51. Exposure to Agent Orange and Hepatocellular Carcinoma Among US Military Personnel. JAMA Netw Open. 2023 12 01; 6(12):e2346380.
    View in: PubMed
    Score: 0.004
  52. Endogenous sex hormones and nonalcoholic fatty liver disease in US adults. Liver Int. 2024 Feb; 44(2):460-471.
    View in: PubMed
    Score: 0.004
  53. Using noninvasive clinical parameters to predict mortality and morbidity after cardiac interventions in patients with cirrhosis: A systematic review. Saudi J Gastroenterol. 2024 Jan 01; 30(1):14-22.
    View in: PubMed
    Score: 0.004
  54. Predictive Algorithm for Hepatic Steatosis Detection Using Elastography Data in the Veterans Affairs Electronic Health Records. Dig Dis Sci. 2023 12; 68(12):4474-4484.
    View in: PubMed
    Score: 0.004
  55. Chronic liver disease-related mortality during the COVID-19 pandemic. Eur J Intern Med. 2023 12; 118:129-132.
    View in: PubMed
    Score: 0.004
  56. Metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality among adults in the United States. J Hepatol. 2024 02; 80(2):e79-e81.
    View in: PubMed
    Score: 0.004
  57. Depression in nonalcoholic fatty liver disease and all-cause/cause-specific mortality. Eur J Clin Invest. 2024 Jan; 54(1):e14087.
    View in: PubMed
    Score: 0.004
  58. Cost of Care for Patients With Cirrhosis. Am J Gastroenterol. 2024 03 01; 119(3):497-504.
    View in: PubMed
    Score: 0.004
  59. Biliary atresia and liver transplantation in the United States: A contemporary analysis. Liver Int. 2023 10; 43(10):2198-2209.
    View in: PubMed
    Score: 0.004
  60. Trends in mortality of liver cancer before and during the COVID-19 pandemic, 2017-2021. Liver Int. 2023 09; 43(9):1865-1870.
    View in: PubMed
    Score: 0.004
  61. The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure. J Hepatol. 2023 09; 79(3):717-727.
    View in: PubMed
    Score: 0.004
  62. Trends in aetiology-based hospitalisation for cirrhosis before and during the COVID-19 pandemic in the United States. Aliment Pharmacol Ther. 2023 07; 58(2):218-228.
    View in: PubMed
    Score: 0.004
  63. Transplanting hepatitis B surface antigen-positive livers in the United States: Outcomes and opportunities. Am J Transplant. 2023 08; 23(8):1221-1226.
    View in: PubMed
    Score: 0.004
  64. Association between depression and metabolic dysfunction-associated fatty liver disease/significant fibrosis. J Affect Disord. 2023 05 15; 329:184-191.
    View in: PubMed
    Score: 0.004
  65. Disparities in primary pancreatic adenocarcinoma survival by Medicaid-status: A national population-based risk analysis. Eur J Surg Oncol. 2023 07; 49(7):1242-1249.
    View in: PubMed
    Score: 0.004
  66. Telehealth interventions in patients with chronic liver diseases: A systematic review. Hepatology. 2023 07 01; 78(1):179-194.
    View in: PubMed
    Score: 0.004
  67. Muscle strength in non-alcoholic fatty liver disease and all-cause and cause-specific mortality. Liver Int. 2023 02; 43(2):513-516.
    View in: PubMed
    Score: 0.004
  68. Disparities in hepatocellular carcinoma survival by Medicaid-status: A national population-based risk analysis. Eur J Surg Oncol. 2023 04; 49(4):794-801.
    View in: PubMed
    Score: 0.004
  69. Is Liver Transplant Justified at Any MELD Score? Transplantation. 2023 03 01; 107(3):680-692.
    View in: PubMed
    Score: 0.004
  70. Chronic liver disease-related mortality in diabetes before and during the COVID-19 in the United States. Dig Liver Dis. 2023 01; 55(1):3-10.
    View in: PubMed
    Score: 0.004
  71. Changing trends in aetiology-based hospitalizations with end-stage liver disease in the United States from 2016 to 2019. Liver Int. 2022 11; 42(11):2390-2395.
    View in: PubMed
    Score: 0.004
  72. Contemporary Changes in Etiology for Hepatocellular Carcinoma in Liver Transplantation. Clin Gastroenterol Hepatol. 2023 08; 21(9):2410-2412.e1.
    View in: PubMed
    Score: 0.004
  73. Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States. Clin Gastroenterol Hepatol. 2022 10; 20(10):2307-2316.e3.
    View in: PubMed
    Score: 0.004
  74. Clinical Course and Outcomes of Patients with Nonalcoholic Fatty Liver Disease-Related Hepatocellular Cancer (NAFLD-HCC). Dig Dis Sci. 2023 03; 68(3):1060-1070.
    View in: PubMed
    Score: 0.004
  75. Trends in All-Cause and Cause-Specific Mortality Among Individuals With Diabetes Before and During the COVID-19 Pandemic in the U.S. Diabetes Care. 2022 06 02; 45(6):e107-e109.
    View in: PubMed
    Score: 0.004
  76. Gallstone Disease and Its Association With Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality. Clin Gastroenterol Hepatol. 2023 04; 21(4):940-948.e2.
    View in: PubMed
    Score: 0.004
  77. Significant improvements, but consistent disparities in survival for African Americans after liver transplantation. Clin Transplant. 2022 06; 36(6):e14646.
    View in: PubMed
    Score: 0.004
  78. DETECT: Development of Technologies for Early HCC Detection. Gastroenterology. 2022 07; 163(1):21-27.
    View in: PubMed
    Score: 0.004
  79. Marginal allografts in liver transplantation have a limited impact on length of stay. Clin Transplant. 2022 03; 36(3):e14544.
    View in: PubMed
    Score: 0.004
  80. Trends in the Prevalence of Hepatitis C Virus Infection based on the Insurance Status in the United States from 2013 to 2018. Liver Int. 2022 02; 42(2):340-349.
    View in: PubMed
    Score: 0.004
  81. Sex-Specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis. J Addict Med. 2022 Jul-Aug 01; 16(4):e248-e256.
    View in: PubMed
    Score: 0.004
  82. Association of Anti-TNF Therapy With Increased Risk of Acute Cholangitis in Patients With Primary Sclerosing Cholangitis. Inflamm Bowel Dis. 2021 10 18; 27(10):1602-1609.
    View in: PubMed
    Score: 0.004
  83. Management of Cardiometabolic Complications in Patients With Nonalcoholic Fatty Liver Disease: A Review of the Literature With Recommendations. J Clin Gastroenterol. 2021 10 01; 55(9):747-756.
    View in: PubMed
    Score: 0.004
  84. Elevated serum sodium in recipients of liver transplantation has a substantial impact on outcomes. Transpl Int. 2021 Oct; 34(10):1971-1983.
    View in: PubMed
    Score: 0.004
  85. Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic. Clin Gastroenterol Hepatol. 2021 12; 19(12):2664-2666.e2.
    View in: PubMed
    Score: 0.004
  86. Physical Activity Is Associated With Nonalcoholic Fatty Liver Disease and Significant Fibrosis Measured by FibroScan. Clin Gastroenterol Hepatol. 2022 06; 20(6):e1438-e1455.
    View in: PubMed
    Score: 0.004
  87. Trends in the Mortality of Biliary Tract Cancers Based on Their Anatomical Site in the United States From 2009 to 2018. Am J Gastroenterol. 2021 05 01; 116(5):1053-1062.
    View in: PubMed
    Score: 0.004
  88. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States. Liver Int. 2021 08; 41(8):1832-1840.
    View in: PubMed
    Score: 0.004
  89. Prevalence of Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis Among US Adults with Prediabetes and Diabetes, NHANES 2017-2018. J Gen Intern Med. 2022 01; 37(1):261-263.
    View in: PubMed
    Score: 0.004
  90. Trends in mortality in hepatitis C infection and alcoholic liver disease based on drug overdose in the United States. J Viral Hepat. 2021 02; 28(2):436-439.
    View in: PubMed
    Score: 0.004
  91. Nationwide Evolution of Pediatric Endoscopic Retrograde Cholangiopancreatography Indications, Utilization, and Readmissions over?Time. J Pediatr. 2021 05; 232:159-165.e1.
    View in: PubMed
    Score: 0.004
  92. Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease. Hepatology. 2020 11; 72(5):1556-1568.
    View in: PubMed
    Score: 0.004
  93. Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality. Am J Gastroenterol. 2020 09; 115(9):1496-1504.
    View in: PubMed
    Score: 0.004
  94. Prevalence of Fatty Liver Disease and Fibrosis Detected by Transient Elastography in Adults in the United States, 2017-2018. Clin Gastroenterol Hepatol. 2021 07; 19(7):1499-1501.e2.
    View in: PubMed
    Score: 0.004
  95. Physical Activity, Measured Objectively, Is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2021 06; 19(6):1240-1247.e5.
    View in: PubMed
    Score: 0.004
  96. Implementation and Impact of Universal Preprocedure Testing of Patients for COVID-19 Before Endoscopy. Gastroenterology. 2020 Oct; 159(4):1586-1588.e4.
    View in: PubMed
    Score: 0.004
  97. Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA. Dig Dis Sci. 2021 05; 66(5):1461-1476.
    View in: PubMed
    Score: 0.004
  98. Decline in Annual Mortality of Hepatitis C Virus-Related Hepatocellular Carcinoma in the United States, From 2009 to 2018. Gastroenterology. 2020 10; 159(4):1558-1560.e2.
    View in: PubMed
    Score: 0.003
  99. Accuracy of Noninvasive Fibrosis Scoring Systems in African American and White Patients With Nonalcoholic Fatty Liver Disease. Clin Transl Gastroenterol. 2020 04; 11(4):e00165.
    View in: PubMed
    Score: 0.003
  100. Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014. Dig Dis Sci. 2021 01; 66(1):296-307.
    View in: PubMed
    Score: 0.003
  101. The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study. Drug Alcohol Depend. 2020 04 01; 209:107917.
    View in: PubMed
    Score: 0.003
  102. Diet quality and its association with nonalcoholic fatty liver disease and all-cause and cause-specific mortality. Liver Int. 2020 04; 40(4):815-824.
    View in: PubMed
    Score: 0.003
  103. Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease. J Palliat Med. 2020 01; 23(1):97-106.
    View in: PubMed
    Score: 0.003
  104. Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study. Dig Dis Sci. 2020 04; 65(4):990-1002.
    View in: PubMed
    Score: 0.003
  105. Depression is associated with non-alcoholic fatty liver disease among adults in the United States. Aliment Pharmacol Ther. 2019 09; 50(5):590-598.
    View in: PubMed
    Score: 0.003
  106. Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017. Gastroenterology. 2019 10; 157(4):1055-1066.e11.
    View in: PubMed
    Score: 0.003
  107. Increasing Mortality Among Patients With Diabetes and Chronic Liver Disease From 2007 to 2017. Clin Gastroenterol Hepatol. 2020 04; 18(4):992-994.
    View in: PubMed
    Score: 0.003
  108. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014. Liver Int. 2019 09; 39(9):1661-1671.
    View in: PubMed
    Score: 0.003
  109. Hepatocellular carcinoma is leading in cancer-related disease burden among hospitalized baby boomers. Ann Hepatol. 2019 Sep - Oct; 18(5):679-684.
    View in: PubMed
    Score: 0.003
  110. Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017. Diabetologia. 2019 07; 62(7):1185-1194.
    View in: PubMed
    Score: 0.003
  111. Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States. Liver Int. 2019 07; 39(7):1335-1342.
    View in: PubMed
    Score: 0.003
  112. Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis. Liver Transpl. 2019 03; 25(3):399-410.
    View in: PubMed
    Score: 0.003
  113. Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States. Hepatology. 2019 03; 69(3):1064-1074.
    View in: PubMed
    Score: 0.003
  114. Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2019 02; 31(2):149-156.
    View in: PubMed
    Score: 0.003
  115. Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016. Hepatol Int. 2019 Mar; 13(2):205-213.
    View in: PubMed
    Score: 0.003
  116. An Unexpected Colonic Mass. Am J Gastroenterol. 2019 01; 114(1):180-181.
    View in: PubMed
    Score: 0.003
  117. Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis. Hepatol Int. 2019 Jan; 13(1):84-90.
    View in: PubMed
    Score: 0.003
  118. Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States. Clin Gastroenterol Hepatol. 2019 10; 17(11):2379-2381.
    View in: PubMed
    Score: 0.003
  119. Early Liver Transplantation is a Viable Treatment Option in Severe Acute Alcoholic Hepatitis. Alcohol Alcohol. 2018 Nov 01; 53(6):716-718.
    View in: PubMed
    Score: 0.003
  120. Disparate Trends in Mortality of Etiology-Specific Chronic Liver Diseases Among Hispanic Subpopulations. Clin Gastroenterol Hepatol. 2019 07; 17(8):1607-1615.e2.
    View in: PubMed
    Score: 0.003
  121. Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016. J Viral Hepat. 2018 12; 25(12):1608-1616.
    View in: PubMed
    Score: 0.003
  122. Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016. Gastroenterology. 2018 10; 155(4):1154-1163.e3.
    View in: PubMed
    Score: 0.003
  123. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy. Dig Dis Sci. 2018 Jun; 63(6):1647-1653.
    View in: PubMed
    Score: 0.003
  124. Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates. World J Gastroenterol. 2018 Jan 21; 24(3):315-322.
    View in: PubMed
    Score: 0.003
  125. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World J Gastroenterol. 2017 Dec 21; 23(47):8263-8276.
    View in: PubMed
    Score: 0.003
  126. Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis. Nutrients. 2017 Oct 13; 9(10).
    View in: PubMed
    Score: 0.003
  127. Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017 Oct; 29(10):1109-1117.
    View in: PubMed
    Score: 0.003
  128. Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2017 Oct; 112(10):1495-1505.
    View in: PubMed
    Score: 0.003
  129. Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United States. Hepatology. 2017 07; 66(1):46-56.
    View in: PubMed
    Score: 0.003
  130. Proton Pump Inhibitors and the Possible Development of Hepatic Encephalopathy in Cirrhotic Patients: True Association or Residual Confounding? Gastroenterology. 2017 06; 152(8):2076.
    View in: PubMed
    Score: 0.003
  131. The Role of e-Health in Optimizing Task-Shifting in the Delivery of Antiviral Therapy for Chronic Hepatitis C. Telemed J E Health. 2017 10; 23(10):870-873.
    View in: PubMed
    Score: 0.003
  132. Are proton pump inhibitors a threat for spontaneous bacterial peritonitis and hepatic encephalopathy in cirrhosis? Not so fast. Hepatology. 2017 01; 65(1):393.
    View in: PubMed
    Score: 0.003
  133. Indications for antiviral therapy for chronic hepatitis B in pregnant mothers. BMJ Case Rep. 2016 Nov 15; 2016.
    View in: PubMed
    Score: 0.003
  134. Task-shifting - A practical strategy to improve the global access to treatment for chronic hepatitis C. Int J Nurs Stud. 2016 Oct; 62:168-9.
    View in: PubMed
    Score: 0.003
  135. The impact of age on nodal metastases and survival in gastric cancer. J Surg Res. 2016 05 15; 202(2):428-35.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.